Page 453 - IJB-9-4
P. 453

International Journal of Bioprinting               Single-step bioink deposition and maturation of human epidermis


            between the body and its surroundings. It not only protects   of application, which is a challenge we are trying to solve
            us from pathogens and harmful substances, but also   in the first place.
            prevents fluid loss to the environment. For a burn patient,   Different biomaterial mixtures have been explored
            restoration of this barrier function is often through the use   in  the  literature  for  epidermis  bioink [10,15,16,20,21,25,41] .  The
            of STSG , though in the most severe cases – precisely the   formulations  typically  contain  natural  polymers  like
                  [2]
            patients most at risk – the lack of donor sites can preclude   fibrinogen [10,15,16,21]   and  collagen [16,20]   which  provide
            its use . CEA is a relatively well-established alternative,   cell adhesion moieties necessary for cell viability.
                 [3]
            though the absence or delayed development of BM between   The bioink may additionally contain hyaluronic acid,
            the epidermis and dermis contributes to its reputation   pectin,  gelatin,  and  glycerol,  among  others,  to  improve
            for fragility, and remains a significant problem [6-8] . While   printability [10,15,20,21,41] .  Previously-reported  in  situ
            “spray-on” skin has shown some encouraging results [8,9,36-38] ,   epidermis printing utilized fibrinogen-based bioink [10,15,16] .
            protocols vary widely [8,38] . Furthermore, some usability   In each report, the final concentration of biomaterial in the
            considerations such as determining where the cells have   bioink is around 2–3% w/v, which, though not too high,
            been applied can be surprisingly challenging, since the
            low-viscosity suspension is not easily visible, and can flow   may be sufficient to affect the compact organization of
                                                                          [10,15,16]
            away from a contoured application site .           the epidermis   . Furthermore, while fibrinogen is a
                                           [10]
                                                               popular biomaterial, heterologous sources of the protein
              In recent years, bioprinting has emerged as a promising   may  cause  severe  immune  reaction .  For  our  bioink
                                                                                             [41]
            approach to restoring tissue function. Compared with   formulation, we chose to use bovine collagen, because it is
            other tissues, skin is a lot more accessible, and existing   very well-established [27,41] , and because the first U.S. Food
            protocols for forming RHEs suggest that self-organization   and Drug Administration (FDA)-approved skin substitute
            of keratinocytes under the right conditions can yield a   also contains bovine collagen . Perhaps because it is
                                                                                        [27]
            functional epidermis [28,39,40] . There are numerous reports   highly conserved cross-species, even heterologous collagen
            that study skin bioprinting [10,15-24] . Most of these studies   causes minimal immunological reactions . To minimize
                                                                                                [41]
            are concerned with in vitro bioprinting [17-24] , where there   the potential regulatory barrier for clinical deployment,
            is greater freedom to manipulate the printed constructs,   we have also kept the composition as simple as possible,
            which may or may not be intended for implantation.   avoiding the use of other biomaterials. Since natural
            On the other hand, few recent works have identified   epidermis does not contain large amounts of collagen
            in situ printing as a possible way to treat wounds, such   type  I, the collagen concentration of our bioink is kept
            as burns [10,15,16,26,27]  (Incidentally, CEA and “spray-on” skin   at a very low concentration of just 0.05% w/v, which was
            can be considered to be rudimentary in vitro and in situ   still sufficient to form a hydrogel, but is unlikely to affect
            bioprinting, respectively.)                        epidermis formation.
              Regardless of the type of bioprinting, the cells are   In general, the previous bioprinting studies had a
            delivered using a bioink, which typically consists of a   strong emphasis on the printing techniques. As a result,
            suitable media or buffer, and may also contain biomaterials   examination of the printed skin was often limited to simple
            that can form hydrogel structures. Unlike the dermis, which   H&E staining and observation of morphological structures.
            has ample extracellular matrix, the epidermis is almost   However, in our experience, care must be taken to analyze
            entirely made up of cell bodies. Consequently, epidermis   the  molecular profile  of  the  printed  skin,  since  simple
            bioprinting is frequently accomplished by depositing cells   histology can miss out on important features. Markers
            suspended in media, without any additional biomaterials,   were therefore chosen to confirm that the printed skin
            directly onto a  dermis or  dermal  template [17-19,22,23] . This   recapitulates the features of the natural tissue, namely skin
            process is akin to the formation of RHE described in the   self-renewal (p63), active growth (Ki67 and K14), barrier
            previous paragraph, and in most cases, the keratinocytes   function (FLG and K10), and mechanical robustness (BM
            are cultured submerged in a pro-proliferation media for   protein ColIV).
            a period of time, before changing to a pro-differentiation
            media and exposing the top surface to air, that is, airlifted.   Since the epidermis is a mostly-flat structure, bioprinting
            This  approach is  not  ideal  for  in situ  printing  for  the   can be accomplished by a “2.5D” approach – depositing a
            following reasons. First, changing of media is difficult   layer of bioink with appreciable thickness, and allowing
            once the bioink is printed on the patient. To address this,   self-organization  to  accomplish  stratification  into  the
            we developed single media formulations that can support   different epidermal layers – instead of the more technically-
                                                                                     [16]
            both proliferation  and  differentiation (Figures  3  and  5).   challenging 3D approach . This also simplifies the
            Second, like “spray-on” skin, the absence of any hydrogel   instrumentation and technique. In this work, our goal
            material can result in the bioink flowing away from the site   was thus to develop a bioink that we can envision being


            Volume 9 Issue 4 (2023)                        445                         https://doi.org/10.18063/ijb.738
   448   449   450   451   452   453   454   455   456   457   458